ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
ENCISION INC
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $163.15K
- P/E (TTM)
- –
- Dividend yield
- –
ENCISION INC revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product [Member] | $6.22M | $6.43M | $6.89M | $6.91M | $7.01M | $7.67M | 94.8% | -3.3% |
| Service [Member] | $337.63K | $153.91K | $463.36K | $753.96K | $527.18K | $0 | 5.2% | +119.4% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Australia | $424.73K | $311.10K | – | – | – | – | 6.5% | +36.5% |
| New Zealand | $62.14K | $48.86K | – | – | – | – | 0.9% | +27.2% |
From the segment and revenue-disaggregation notes of Encision's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.